青木一孝 (Kazutaka Aoki) - マイポータル

基本情報

所属: 神奈川歯科大学全身管理医歯学講座内科(糖尿病・内分泌内科) 教授

学位: 博士（医学）(横浜市立大学)

J-GLOBAL ID: 201201013356133690
researchmap会員ID: 7000002312

外部リンク: http://www.kdu.ac.jp/hospital/103-003-01internal_medicine.html

研究キーワード

内分泌・糖尿病

研究分野

ライフサイエンス / 代謝、内分泌学 /

学歴

1996年4月 - 1999年7月

横浜市立大学大学院医学研究科
1990年4月 - 1996年3月

信州大学医学部

受賞

論文

Usefulness of antidiabetic alpha-glucosidase inhibitors: a review on the timing of administration and effects on gut hormones.

Aoki K, Sato H, Terauchi Y

Endocrine journal 66(5) 395-401 2019年5月査読有り
A Randomized Controlled Trial of a Mini Low-Carbohydrate Diet and an Energy-Controlled Diet Among Japanese Patients With Type 2 Diabetes.

Masayo Kimura, Yoshinobu Kondo, Kazutaka Aoki, Jun Shirakawa, Hiroshi Kamiyama, Kazunari Kamiko, Shigeru Nakajima, Yasuo Terauchi

Journal of clinical medicine research 10(3) 182-188 2018年3月査読有り
Effect of Dehydroepiandrosterone (DHEA) on Diabetes Mellitus and Obesity.

Aoki K, Terauchi Y

Vitamins and hormones 108 355-365 2018年査読有り
Effect of Switching From an Anti-Diabetic Loose Dose Combination to a Fixed Dose Combination Regimen at Equivalent Dosage for 6 Months on Glycemic Control in Japanese Patients With Type 2 Diabetes: A Pilot Study.

Aoki K, Nagakura M, Taguri M, Kamiyama H, Masumura M, Furuie T, Oka M, Kamiko K, Nakajima S, Akema N …

Journal of clinical medicine research 9(8) 719-724 2017年8月査読有り
Comparison of Plasma Glucose and Gut Hormone Levels Between Drinking Enteral Formula Over a Period of 5 and 20 Minutes in Japanese Patients With Type 2 Diabetes: A Pilot Study.

Kamiko K, Aoki K, Kamiyama H, Taguri M, Terauchi Y

Journal of clinical medicine research 8(10) 749-752 2016年10月査読有り
Effect of dehydroepiandrosterone (DHEA) on Akt and protein kinase C zeta (PKCζ) phosphorylation in different tissues of C57BL6, insulin receptor substrate (IRS)1(-/-), and IRS2(-/-) male mice fed a high-fat diet.

Aoki K, Tajima K, Taguri M, Terauchi Y

The Journal of steroid biochemistry and molecular biology 159 110-120 2016年5月査読有り
Comparison of efficacy and safety of taking miglitol dissolved in water during a meal and taking a miglitol tablet just before a meal in patients with type 2 diabetes.

Shibata E, Aoki K, Tajima K, Taguri M, Terauchi Y

Expert opinion on pharmacotherapy 17(7) 1-6 2016年3月査読有り
Effect of Switching from Sulphonylurea to Repaglinide Twice or Three Times Daily for 4 Months on Glycemic Control in Japanese Patients with Type 2 Diabetes

Hiroshi Kamiyama, Kazutaka Aoki, Shigeru Nakajima, Kazuaki Shinoda, Kazunari Kamiko, Masataka Taguri, Yasuo Terauchi

INTERNAL MEDICINE 55(13) 1697-1703 2016年査読有り
Anagliptin decreases serum lathosterol level in patients with type 2 diabetes: a pilot study

Kazutaka Aoki, Takahiro Ijima, Hiroshi Kamiyama, Kazunari Kamiko, Yasuo Terauchi

EXPERT OPINION ON PHARMACOTHERAPY 16(12) 1749-1754 2015年8月査読有り
Comparison of the Administration of Teneligliptin Every Day Versus Every Other Day in Japanese Patients With Type 2 Diabetes: A Randomized Non-Inferior Test

Kazunari Kamiko, Kazutaka Aoki, Hiroshi Kamiyama, Masataka Taguri, Eriko Shibata, Yumiko Ashiya, Fuyuki Minagawa, Kazuaki Shinoda, Shigeru Nakajima, Yasuo Terauchi

JOURNAL OF CLINICAL PHARMACOLOGY 55(2) 144-151 2015年2月査読有り
Effect of repaglinide, administered two or three times daily for 3 months, on glycaemic control in Japanese patients with type 2 diabetes mellitus

Hiroshi Kamiyama, Kazutaka Aoki, Shigeru Nakajima, Kazuaki Shinoda, Kazunari Kamiko, Masataka Taguri, Yasuo Terauchi

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH 42(5) 1150-1160 2014年10月査読有り
Comparison of intragastric balloon therapy and intensive lifestyle modification therapy with respect to weight reduction and abdominal fat distribution in super-obese Japanese patients

Masahiro Takihata, Akinobu Nakamura, Kazutaka Aoki, Mari Kimura, Yusuke Sekino, Masahiko Inamori, Shin Maeda, Eiji Gotoh, Atsushi Nakajima, Yasuo Terauchi

OBESITY RESEARCH & CLINICAL PRACTICE 8(4) E331-E338 2014年7月査読有り
Effects of miglitol, vildagliptin, or their combination on serum insulin and peptide YY levels and plasma glucose, cholecystokinin, ghrelin, and obestatin levels

Kazutaka Aoki, Hiroshi Kamiyama, Kiyomi Masuda, Kazunari Kamiko, Yoshihiko Noguchi, Kazuki Tajima, Yasuo Terauchi

ENDOCRINE JOURNAL 61(3) 249-256 2014年3月査読有り
Effect of Caloric Intake 25 or 30 kcal/kg/day on the Glycemic Control in Obese Patients With Type 2 Diabetes.

Masuda K, Aoki K, Kawaguchi J, Yamakawa T, Matsuba I, Terauchi Y

Journal of clinical medicine research 5(5) 368-375 2013年10月査読有り
Glycemic control after addition of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes showing inadequate response to thrice-a-day treatment with α-glucosidase inhibitors.

Masuda K, Aoki K, Kamiko K, Takihata M, Ito Y, Nagakura M, Kawasaki S, Akema N, Hasegawa M, Nakajima S …

Expert opinion on pharmacotherapy 14(9) 1111-1118 2013年6月査読有り
Mosapride citrate, a 5-HT₄ receptor agonist, increased the plasma active and total glucagon-like peptide-1 levels in non-diabetic men.

Aoki K, Kamiyama H, Masuda K, Togashi Y, Terauchi Y

Endocrine journal 60(4) 493-499 2013年4月査読有り
Trefoil factor 2 promotes cell proliferation in pancreatic β-cells through CXCR-4-mediated ERK1/2 phosphorylation.

Orime K, Shirakawa J, Togashi Y, Tajima K, Inoue H, Ito Y, Sato K, Nakamura A, Aoki K, Goshima Y …

Endocrinology 154(1) 54-64 2013年1月査読有り
AMPK is involved in the regulation of incretin receptors expression in pancreatic islets under a low glucose concentration.

Kazuki Tajima, Jun Shirakawa, Yu Togashi, Hideaki Inoue, Koichiro Sato, Kazuki Orime, Yuzuru Ito, Mitsuyo Kaji, Eri Sakamoto, Akinobu Nakamura …

PloS one 8(5) e64633 2013年査読有り
Effects of Aliskiren-Based Therapy on Ambulatory Blood Pressure Profile, Central Hemodynamics, and Arterial Stiffness in Nondiabetic Mild to Moderate Hypertensive Patients

Tomohiko Kanaoka, Kouichi Tamura, Masato Ohsawa, Hiromichi Wakui, Akinobu Maeda, Toru Dejima, Kengo Azushima, Sona Haku, Hiroshi Mitsuhashi, Mai Yanagi …

JOURNAL OF CLINICAL HYPERTENSION 14(8) 522-529 2012年8月査読有り
Miglitol administered before breakfast increased plasma active glucagon-like peptide-1 (GLP-1) levels after lunch in patients with type 2 diabetes treated with sitagliptin

Kazutaka Aoki, Hiroshi Kamiyama, Kouichiro Yoshimura, Makoto Shibuya, Kiyomi Masuda, Yasuo Terauchi

ACTA DIABETOLOGICA 49(3) 225-230 2012年6月査読有り

もっとみる